Study: Leukemia pill has 86 percent remission rate
Sunday, December 5, 2004 Posted: 11:27 AM EST (1627 GMT)
WASHINGTON (Reuters) -- A next-generation leukemia pill designed to help patients not cured by the successful drug Gleevec works even better than doctors had hoped, researchers said Sunday.
The new drug, made by Bristol-Myers Squibb put 86 percent of patients who tried it into remission -- meaning signs of their cancer disappeared, the researchers said.
Although this was only a Phase I trial meant to show the drug was safe, the effects were dramatic, the doctors told a meeting in San Diego of the American Society of Hematology.
"Certainly it is wonderful. It will save lives," said Dr. Alan Kinniburgh, senior vice president of research for The Leukemia and Lymphoma Society, which helped sponsor the study.
Breakthroughs like this are the real reason why I'm training so hard for this marathon. I truly believe the cure is out there if we're willing to work hard enough for it.
Donate here: http://www.teamintraining.org/participant/bloom-228709